The nootropics market size has grown rapidly in recent years. It will grow from $5.96 billion in 2025 to $6.96 billion in 2026 at a compound annual growth rate (CAGR) of 16.9%. The growth in the historic period can be attributed to limited availability of prescription nootropics, low consumer awareness, dependence on traditional stimulants, high cost of advanced cognitive enhancers, limited online distribution channels.
The nootropics market size is expected to see rapid growth in the next few years. It will grow to $13.23 billion in 2030 at a compound annual growth rate (CAGR) of 17.4%. The growth in the forecast period can be attributed to rising adoption of otc and prescription nootropics, increasing demand for natural and synthetic blends, growth in online and offline distribution, expanding focus on cognitive health and anti-aging, technological innovation in formulations and delivery systems. Major trends in the forecast period include rising demand for cognitive enhancers and prescription nootropics, increasing popularity of otc nootropic supplements, growing adoption of nootropic drinks and powders, rising focus on memory enhancement and mental performance, increasing consumer awareness about mood, sleep, and anti-aging benefits.
The rising expenditure on health and wellness is expected to drive the growth of the nootropics market in the coming years. Health and wellness encompass practices aimed at achieving optimal mental and physical well-being. As awareness and investment in personal health increase, the demand for products that support cognitive function and overall wellness, such as nootropics, rises. Nootropics are supplements designed to enhance memory, focus, mood, and cognitive performance, aligning with the broader health and wellness trend. For instance, in November 2024, the Global Wellness Institute, a US-based research organization, reported that global spending on health and wellness reached US$6.3 trillion in 2023, up from US$5.8 trillion in 2022, and is projected to grow to US$9 trillion by 2028. Therefore, increasing health and wellness expenditure is fueling the nootropics market.
Major companies in the nootropics market are developing multi-flavored nootropic products as part of product line extensions to enhance cognitive and physical wellness. Product line extensions in nutraceuticals involve introducing new variants within an existing health-focused brand portfolio to meet diverse consumer needs and preferences. For example, in June 2023, Rollagranola, a UK-based food and beverage company, launched a nootropic range with four distinct flavors: Calm, Energize, Body and Soul, and Complete Vegan. Calm combines ashwagandha and matcha green tea to promote relaxation and stress reduction. Energize features lion’s mane, caffeine, and panax ginseng in a cappuccino and white chocolate blend to improve focus and energy. Body and Soul mixes summer berries and walnuts with creatine, maca, ginkgo, and panax ginseng to support mental and physical well-being. Complete Vegan is tailored for vegan consumers, offering pea protein, essential nutrients, and key vitamins to enhance memory, focus, and mood.
In August 2024, Paradigm Sports, a US-based sports management service provider, partnered with Ten Percent Club, a UK-based seller of nootropic-based supplements, to expand the use of nootropics in athlete performance. The collaboration aims to educate athletes on cognitive enhancement benefits while offering innovative products for mental preparation, focus, and recovery, helping optimize overall athletic performance through scientifically supported nootropic solutions.
Major companies operating in the nootropics market are Accelerated Intelligence Inc., AlternaScript Inc. Health Via Modern Nutrition Inc., Mental Mojo LLC., Peak Nootropics, PureLife Bioscience Co. Ltd., TruBrain, PepsiCo, Superior Supplement Manufacturing, Equinox Nutraceuticals, Natural Stacks Inc., Gaia Herbs Farms., Kimera Koffee LLC., Onnit Labs LLC., Reckitt Benckiser Group plc., OUTLIERS INC., Teva Pharmaceutical Industries Ltd., United Pharmacies o, Clarity Nootropics, OptiMind, HVMN Inc., BioAdaptives Inc., Powder City.
North America was the largest region in the nootropics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nootropics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the nootropics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have impacted the nootropics market by increasing costs of imported capsules, powders, and drinks, affecting both prescription and otc segments. Online and offline distribution channels in regions like north america, europe, and asia-pacific face higher procurement costs. While tariffs may limit product affordability temporarily, they also encourage local manufacturing, support domestic supplement production, and drive innovation in cost-effective and advanced formulations.
The nootropics market research report is one of a series of new reports that provides nootropics market statistics, including nootropics industry global market size, regional shares, competitors with a nootropics market share, detailed nootropics market segments, market trends and opportunities, and any further data you may need to thrive in the nootropics industry. This nootropics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Nootropics are substances that enhance memory and provide stimulating effects to boost brain performance. They include compounds such as caffeine, creatine, vitamins, and minerals, which are used to improve memory, strength, or other cognitive functions. While they may influence memory, thinking, or other mental abilities, they are not used to treat diseases.
The main types of nootropic drugs are prescription nootropics and over-the-counter (OTC) nootropics. Prescription nootropics provide stimulant effects to help manage symptoms of conditions such as attention deficit hyperactivity disorder (ADHD), Alzheimer’s disease, or narcolepsy. They are available in various forms, including capsules, tablets, powders, drinks, and others, and are distributed through both online and offline channels. Nootropics are used for applications such as memory enhancement, mood and depression management, attention and focus improvement, longevity and anti-aging, sleep and recovery support, and anxiety treatment.
The nootropics market includes revenues earned by entities by modafinil (provigil), adderall, methylphenidate (ritalin), memantine (axura), caffeine, l-theanine, and omega-3 fatty acids. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The nootropics market size is expected to see rapid growth in the next few years. It will grow to $13.23 billion in 2030 at a compound annual growth rate (CAGR) of 17.4%. The growth in the forecast period can be attributed to rising adoption of otc and prescription nootropics, increasing demand for natural and synthetic blends, growth in online and offline distribution, expanding focus on cognitive health and anti-aging, technological innovation in formulations and delivery systems. Major trends in the forecast period include rising demand for cognitive enhancers and prescription nootropics, increasing popularity of otc nootropic supplements, growing adoption of nootropic drinks and powders, rising focus on memory enhancement and mental performance, increasing consumer awareness about mood, sleep, and anti-aging benefits.
The rising expenditure on health and wellness is expected to drive the growth of the nootropics market in the coming years. Health and wellness encompass practices aimed at achieving optimal mental and physical well-being. As awareness and investment in personal health increase, the demand for products that support cognitive function and overall wellness, such as nootropics, rises. Nootropics are supplements designed to enhance memory, focus, mood, and cognitive performance, aligning with the broader health and wellness trend. For instance, in November 2024, the Global Wellness Institute, a US-based research organization, reported that global spending on health and wellness reached US$6.3 trillion in 2023, up from US$5.8 trillion in 2022, and is projected to grow to US$9 trillion by 2028. Therefore, increasing health and wellness expenditure is fueling the nootropics market.
Major companies in the nootropics market are developing multi-flavored nootropic products as part of product line extensions to enhance cognitive and physical wellness. Product line extensions in nutraceuticals involve introducing new variants within an existing health-focused brand portfolio to meet diverse consumer needs and preferences. For example, in June 2023, Rollagranola, a UK-based food and beverage company, launched a nootropic range with four distinct flavors: Calm, Energize, Body and Soul, and Complete Vegan. Calm combines ashwagandha and matcha green tea to promote relaxation and stress reduction. Energize features lion’s mane, caffeine, and panax ginseng in a cappuccino and white chocolate blend to improve focus and energy. Body and Soul mixes summer berries and walnuts with creatine, maca, ginkgo, and panax ginseng to support mental and physical well-being. Complete Vegan is tailored for vegan consumers, offering pea protein, essential nutrients, and key vitamins to enhance memory, focus, and mood.
In August 2024, Paradigm Sports, a US-based sports management service provider, partnered with Ten Percent Club, a UK-based seller of nootropic-based supplements, to expand the use of nootropics in athlete performance. The collaboration aims to educate athletes on cognitive enhancement benefits while offering innovative products for mental preparation, focus, and recovery, helping optimize overall athletic performance through scientifically supported nootropic solutions.
Major companies operating in the nootropics market are Accelerated Intelligence Inc., AlternaScript Inc. Health Via Modern Nutrition Inc., Mental Mojo LLC., Peak Nootropics, PureLife Bioscience Co. Ltd., TruBrain, PepsiCo, Superior Supplement Manufacturing, Equinox Nutraceuticals, Natural Stacks Inc., Gaia Herbs Farms., Kimera Koffee LLC., Onnit Labs LLC., Reckitt Benckiser Group plc., OUTLIERS INC., Teva Pharmaceutical Industries Ltd., United Pharmacies o, Clarity Nootropics, OptiMind, HVMN Inc., BioAdaptives Inc., Powder City.
North America was the largest region in the nootropics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nootropics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the nootropics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have impacted the nootropics market by increasing costs of imported capsules, powders, and drinks, affecting both prescription and otc segments. Online and offline distribution channels in regions like north america, europe, and asia-pacific face higher procurement costs. While tariffs may limit product affordability temporarily, they also encourage local manufacturing, support domestic supplement production, and drive innovation in cost-effective and advanced formulations.
The nootropics market research report is one of a series of new reports that provides nootropics market statistics, including nootropics industry global market size, regional shares, competitors with a nootropics market share, detailed nootropics market segments, market trends and opportunities, and any further data you may need to thrive in the nootropics industry. This nootropics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Nootropics are substances that enhance memory and provide stimulating effects to boost brain performance. They include compounds such as caffeine, creatine, vitamins, and minerals, which are used to improve memory, strength, or other cognitive functions. While they may influence memory, thinking, or other mental abilities, they are not used to treat diseases.
The main types of nootropic drugs are prescription nootropics and over-the-counter (OTC) nootropics. Prescription nootropics provide stimulant effects to help manage symptoms of conditions such as attention deficit hyperactivity disorder (ADHD), Alzheimer’s disease, or narcolepsy. They are available in various forms, including capsules, tablets, powders, drinks, and others, and are distributed through both online and offline channels. Nootropics are used for applications such as memory enhancement, mood and depression management, attention and focus improvement, longevity and anti-aging, sleep and recovery support, and anxiety treatment.
The nootropics market includes revenues earned by entities by modafinil (provigil), adderall, methylphenidate (ritalin), memantine (axura), caffeine, l-theanine, and omega-3 fatty acids. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Nootropics Market Characteristics
3. Nootropics Market Supply Chain Analysis
4. Global Nootropics Market Trends and Strategies
5. Nootropics Market Analysis of End Use Industries
7. Global Nootropics Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Nootropics Total Addressable Market (TAM) Analysis for the Market
9. Nootropics Market Segmentation
10. Nootropics Market Regional and Country Analysis
11. Asia-Pacific Nootropics Market
12. China Nootropics Market
13. India Nootropics Market
14. Japan Nootropics Market
15. Australia Nootropics Market
16. Indonesia Nootropics Market
17. South Korea Nootropics Market
18. Taiwan Nootropics Market
19. South East Asia Nootropics Market
20. Western Europe Nootropics Market
21. UK Nootropics Market
22. Germany Nootropics Market
23. France Nootropics Market
24. Italy Nootropics Market
25. Spain Nootropics Market
26. Eastern Europe Nootropics Market
27. Russia Nootropics Market
28. North America Nootropics Market
29. USA Nootropics Market
30. Canada Nootropics Market
31. South America Nootropics Market
32. Brazil Nootropics Market
33. Middle East Nootropics Market
34. Africa Nootropics Market
36. Nootropics Market Competitive Landscape and Company Profiles
37. Nootropics Market Other Major and Innovative Companies
40. Nootropics Market High Potential Countries, Segments and Strategies
41. Appendix
Executive Summary
Nootropics Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses nootropics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for nootropics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The nootropics market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Drug Type: Prescription Nootropics; Over-The-Counter (OTC) Nootropics2) By Form: Capsules Or Tablets; Powder; Drinks; Other Forms
3) By Distribution Channel: Offline; Online
4) By Application: Memory Enhancement; Mood And Depression; Attention And Focus; Sleep And Recovery; Anxiety
Subsegments:
1) By Prescription Nootropics: Stimulants; Cognitive Enhancers2) By Over-The-Counter (OTC) Nootropics: Natural Nootropics; Synthetic Nootropics; Nootropic Blends
Companies Mentioned: Accelerated Intelligence Inc.; AlternaScript Inc. Health Via Modern Nutrition Inc.; Mental Mojo LLC.; Peak Nootropics; PureLife Bioscience Co. Ltd.; TruBrain; PepsiCo; Superior Supplement Manufacturing; Equinox Nutraceuticals; Natural Stacks Inc.; Gaia Herbs Farms.; Kimera Koffee LLC.; Onnit Labs LLC.; Reckitt Benckiser Group plc.; OUTLIERS INC.; Teva Pharmaceutical Industries Ltd.; United Pharmacies o; Clarity Nootropics; OptiMind; HVMN Inc.; BioAdaptives Inc.; Powder City
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Nootropics market report include:- Accelerated Intelligence Inc.
- AlternaScript Inc. Health Via Modern Nutrition Inc.
- Mental Mojo LLC.
- Peak Nootropics
- PureLife Bioscience Co. Ltd.
- TruBrain
- PepsiCo
- Superior Supplement Manufacturing
- Equinox Nutraceuticals
- Natural Stacks Inc.
- Gaia Herbs Farms.
- Kimera Koffee LLC.
- Onnit Labs LLC.
- Reckitt Benckiser Group plc.
- OUTLIERS INC.
- Teva Pharmaceutical Industries Ltd.
- United Pharmacies o
- Clarity Nootropics
- OptiMind
- HVMN Inc.
- BioAdaptives Inc.
- Powder City
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 6.96 Billion |
| Forecasted Market Value ( USD | $ 13.23 Billion |
| Compound Annual Growth Rate | 17.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |
